Bristol-Myers Squibb Company
NYSE: BMY
$58.50
+$0.09 (+0.2%)
Closing Price on November 14, 2024
BMY Articles
Bristol-Myers Squibb shares dipped on Tuesday after the company reported results from its late-stage lung cancer study.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Here is a preview of some of the world’s largest players in the health care sector reporting earnings this coming week.
Published:
Last Updated:
Compugen shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb will make a $12 million equity investment as part of its collaboration on a cancer trial.
Published:
Last Updated:
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Here are the 15 companies that appear most likely to enter or get back into the $100 billion market capitalization club among U.S. stocks.
Published:
Last Updated:
The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
Published:
Last Updated:
Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good print from Johnson & Johnson as a good signal for the...
Published:
Last Updated: